Avenova: The Missing Piece in your
Hygiene Management of MGD Dry Eye
AVENOVA® sets a new standard of care in the management of MGD Dry Eye. Avenova is the only pure hypochlorous acid (HOCl) product shown to safely manage bioburden on the lids and lashes. This is important when managing MGD patients chronically, as Avenova is the only HOCl product FDA cleared for safe, long-term use while reducing bacterial load on the lids and lashes, helping keep your patients' lids healthy.
Manages Bacteria Overpopulation1
In a study published in Clinical Ophthalmology, Avenova was shown to reduce the bacterial load significantly without altering the diversity of bacterial species remaining on the skin.1
Penetrates Biofilm, killing underlying pathogens2
Avenova has been shown to penetrate biofilm and kill the underlying pathogens.
Inactivates Lipase3
Avenova has been tested to inactivate lipase.
In Vitro Comparisons with Betadine4
Avenova has a wider microbial spectrum than Betadine, covering additional bacterial strains.
Partner with Avenova!
Rethink your Management of MGD Dry Eye
- Stroman, DW. Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin. Clinical Ophthalmology 2017:11 1-8. Reduction in microbial growth in the solution has not been shown to correlate with a reduction of infections in patients. Clinical studies to evaluate reduction in infection have not been performed.
- Romanowski E., Stella N.A., Yates K., Brothers K., Kowalski R.P., Shanks R.M.Q., In Vitro Evaluation of a Hypochlorous Acid Hygiene Solution on Established Biofilms. University of Pittsburgh, 2017
- Epstein A, Pang L, Najafi-Tagol K, Najafi R, Stroman DW, Debabov D. Comparison of Bacterial Lipase Activity in the Presence of Eye Lid Cleansers. Presented at ARVO 2013 in Denver, CO.
- Klocek, M.S., Mammen, A., Dhaliwal, D., Kowalski, R. Time-Kill Comparison of Povidone Iodine to Hypochlorous Acid against Endophthalmitis Isolates of Staphylococci. ARVO Annual Meeting 2016 Abstract Number 5861